We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+6.29%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$121B
AUM Growth
+$6.29B
Cap. Flow
+$257M
Cap. Flow %
0.21%
Top 10 Hldgs %
24.67%
Holding
4,045
New
183
Increased
1,650
Reduced
1,805
Closed
213

Sector Composition

Rank Sector Weight
1 Technology 15.49%
2 Financials 8.61%
3 Healthcare 8.48%
4 Industrials 6.86%
5 Consumer Discretionary 5.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VISN
2851
Vistance Networks Inc
VISN
$2.62B
$568K ﹤0.01%
100,874
-591
-0.6% -$2.83K
KE
2852
Kimball Electronics
KE
$626M
$567K ﹤0.01%
20,533
-108
-0.5% -$2.56K
CYH icon
2853
Community Health Systems
CYH
$419M
$567K ﹤0.01%
128,782
+97
+0.1% +$413
ARI
2854
Apollo Commercial Real Estate
ARI
$886M
$566K ﹤0.01%
49,970
-5,090
-9% -$51.4K
RPT
2855
Rithm Property Trust
RPT
$101M
$565K ﹤0.01%
15,371
-50
-0.3% -$1.8K
NMFC icon
2856
New Mountain Finance
NMFC
$736M
$563K ﹤0.01%
45,273
+47
+0.1% +$567
JHML icon
2857
John Hancock Multifactor Large Cap ETF
JHML
$1.21B
$563K ﹤0.01%
10,253
+1,770
+21% +$92.8K
MHI
2858
DELISTED
Pioneer Municipal High Income Fund
MHI
$563K ﹤0.01%
65,979
+3,396
+5% +$29.2K
HL icon
2859
Hecla Mining
HL
$11.9B
$563K ﹤0.01%
109,272
-6,123
-5% -$35K
TRND icon
2860
Pacer Trendpilot Fund of Funds ETF
TRND
$64.2M
$562K ﹤0.01%
19,334
KYMR icon
2861
Kymera Therapeutics
KYMR
$9.51B
$561K ﹤0.01%
24,409
+1,478
+6% +$42.4K
VBF icon
2862
Invesco Bond Fund
VBF
$169M
$560K ﹤0.01%
37,654
-2,429
-6% -$37.1K
LRN icon
2863
Stride
LRN
$3.48B
$559K ﹤0.01%
15,010
-179
-1% -$7.16K
LTC
2864
LTC Properties
LTC
$2.1B
$557K ﹤0.01%
16,880
-543
-3% -$18.1K
ZURA icon
2865
Zura Bio
ZURA
$540M
$557K ﹤0.01%
+67,875
New +$545K
FJUL icon
2866
FT Vest US Equity Buffer ETF July
FJUL
$1.27B
$556K ﹤0.01%
14,251
ICMB icon
2867
Investcorp Credit Management BDC
ICMB
$11.9M
$556K ﹤0.01%
153,472
-18,760
-11% -$68.2K
KRTX
2868
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$556K ﹤0.01%
2,562
-525
-17% -$112K
KMT icon
2869
Kennametal
KMT
$2.32B
$555K ﹤0.01%
19,541
-474
-2% -$12.7K
POCT icon
2870
Innovator US Equity Power Buffer ETF October
POCT
$975M
$555K ﹤0.01%
16,571
+767
+5% +$24.8K
B
2871
CALL
Barrick Mining
B
$67.3B
$554K ﹤0.01%
34,600
BATRK icon
2872
Atlanta Braves Holdings Series B
BATRK
$3.41B
$553K ﹤0.01%
13,963
+54
+0.4% +$2.03K
ZTR
2873
Virtus Total Return Fund
ZTR
$338M
$552K ﹤0.01%
90,855
+1,026
+1% +$6.4K
BWX icon
2874
State Street SPDR Bloomberg International Treasury Bond ETF
BWX
$1.31B
$552K ﹤0.01%
24,471
-462
-2% -$10.5K
BKE icon
2875
Buckle
BKE
$2.31B
$552K ﹤0.01%
15,943
+1,414
+10% +$47.4K

Similar funds

Raymond James & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Raymond James & Associates held 4,045 positions worth $121B, up 5.5% from $115B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Raymond James & Associates's Q2 2023 filing shows 183 new, 1,650 increased, 1,805 reduced and 213 closed positions. Its largest new stake was Choice Hotels: 212,259 shares worth $24.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $562M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2023 buy was Choice Hotels: 212,259 shares worth $24.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2023, an estimated $753M increase.
  • Raymond James & Associates's biggest Q2 2023 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $562M.
  • Raymond James & Associates fully exited ABB Ltd in Q2 2023, selling an estimated $17.1M.
  • Raymond James & Associates's ten largest holdings make up 25% of its $121B portfolio in Q2 2023.
  • Raymond James & Associates opened 183 new positions and closed 213 in Q2 2023.
  • Raymond James & Associates's portfolio value rose 5.5% quarter-over-quarter to $121B.

Based on Raymond James & Associates's 13F filing for Q2 2023, filed 25 Jul 2023.